← Back to catalogue

DG Gel 8 Anti-e

FDA UDI

by Diagnostic Grifols Sa

Identity

Trade Name
DG Gel 8 Anti-e FDA UDI
Generic Name
Rhesus (Rh) phenotype (CcDEe) multiple blood grouping IVD, kit, agglutination FDA UDI
Device Name
For the determination of human e antigen on the surface of red blood cells of eight human blood samples. For use with the DG Gel System. For in vitro diagnostic use. FDA UDI
Model / Reference
210227 FDA UDI
Description
For the determination of human e antigen on the surface of red blood cells of eight human blood samples. For use with the DG Gel System. For in vitro diagnostic use. FDA UDI

Identifiers

Catalog Number
210227 FDA UDI
Primary DI / UDI-DI
08436583731086 FDA UDI
GMDN Term
Rhesus (Rh) phenotype (CcDEe) multiple blood grouping IVD, kit, agglutination FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Rhesus (Rh) phenotype (CcDEe) multiple blood grouping IVD, kit, agglutination

DG Gel 8 Anti-e by Diagnostic Grifols Sa — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Rhesus (Rh) phenotype (CcDEe) multiple blood grouping IVD, kit, agglutination.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Diagnostic Grifols Sa

Sources (1)

  • FDA UDI a9ceb999-00a6-4c27-9acf-faa275989feb 36 fields · synced May 30, 2026